Table 2.
Characteristics | OR (95% CI) | p-value |
---|---|---|
Locationa | ||
West | Reference | |
East | 1.02 (0.62–1.68) | |
Mid-southwest | 1.72 (0.99–2.97) | 0.146 |
Age at diagnosis, years | ||
15–19 | Reference | |
20–24 | 1.44 (0.79–2.60) | |
25–29 | 3.03 (1.68–5.48) | |
30–34 | 3.21 (1.75–5.90) | |
35–39 | 4.03 (2.18–7.45) | <0.001 |
Sex | ||
Male | Reference | |
Female | 1.18 (0.78–1.79) | 0.422 |
Race/ethnicity | ||
NH white | Reference | |
Hispanic | 0.60 (0.40–0.91) | |
NH black | 0.47 (0.17–1.30) | |
Other | 1.38 (0.67–2.86) | 0.024 |
Heath insurance | ||
Private | Reference | |
Public/no/unknown | 0.51 (0.34–0.76) | <0.001 |
Incomeb | ||
<55 | Reference | |
55–75 | 1.71 (0.85–3.42) | |
≥75 | 1.30 (0.62–2.71) | 0.201 |
Comorbidities | ||
No | Reference | |
Yes | 1.59 (1.08–2.34) | 0.019 |
ALL histology | ||
B cell | Reference | |
T cell | 0.73 (0.42–1.29) | 0.283 |
ALL cytogenetic risk | ||
Standard risk | ||
High risk | 4.75 (3.13–7.21) | <0.001 |
CNS involvement | ||
No | Reference | |
Yes | 0.81 (0.43–1.50) | 0.454 |
Physician specialty | ||
Pediatric oncology | Reference | |
Adult hematology oncology | 2.61 (1.68–4.05) | <0.001 |
Treating facility | ||
Large teaching hospital | Reference | |
Nonteaching hospital | 0.59 (0.31–1.11) | |
Small teaching hospital | 0.81 (0.54–1.23) | 0.229 |
Induction regimen | ||
Asparaginase containing | Reference | |
Hyper-CVAD | 2.86 (1.91–4.29) | |
Other/unknown | 0.25 (0.07–0.92) | <0.001 |
Analyses exclude 32 patients who had relapse/progression or died within 3 months of diagnosis.
East: Atlanta (Metropolitan), Connecticut, New Jersey, Kentucky, Louisiana; Mid-southwest: Detroit (Metropolitan), Iowa, Utah, New Mexico; West: San Francisco (Oakland), San Jose-Monterey, Seattle (Puget Sound), Hawaii, Los Angeles, California other.
Census tract medium family income, in thousands of dollars.
OR, odds ratio; CI, confidence interval.